Published in Diabetes Care on September 01, 1997
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern Med (2014) 2.25
Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med (2014) 2.20
Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol (2008) 2.04
Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study. Eur Heart J (2011) 1.79
Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant (2009) 1.71
Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia (2007) 1.59
Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology (2009) 1.48
Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ (2004) 1.36
Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ (2007) 1.34
Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther (2012) 1.30
Aging, vascular risk, and cognition: blood glucose, pulse pressure, and cognitive performance in healthy adults. Psychol Aging (2009) 1.22
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. Psychosom Med (2007) 1.22
High blood pressure and cognitive decline in mild cognitive impairment. J Am Geriatr Soc (2013) 1.09
Vascularization pattern after ischemic stroke is different in control versus diabetic rats: relevance to stroke recovery. Stroke (2013) 1.05
Cardiovascular health and cognitive function: the Maine-Syracuse Longitudinal Study. PLoS One (2014) 0.99
Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. J Neurochem (2010) 0.96
Midlife hypertensive status and cognitive function 20 years later: the Southall and Brent revisited study. J Am Geriatr Soc (2013) 0.93
Alerting, orienting, and executive attention in older adults. J Int Neuropsychol Soc (2010) 0.93
Diet-induced metabolic disturbances as modulators of brain homeostasis. Biochim Biophys Acta (2008) 0.91
Effects of health status on word finding in aging. J Am Geriatr Soc (2009) 0.89
Testing covariates of Type 2 diabetes-cognition associations in older adults: moderating or mediating effects? Neuropsychology (2010) 0.88
Human hippocampal energy metabolism is impaired during cognitive activity in a lipid infusion model of insulin resistance. Brain Behav (2013) 0.88
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87
The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) (2014) 0.86
Impaired cognition preceding cardiac surgery is related to cerebral ischemic lesions. J Anesth (2011) 0.85
The Framingham Heart Study - 67 years of discovery in metabolic disease. Nat Rev Endocrinol (2016) 0.84
The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition. J Alzheimers Dis (2014) 0.84
Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults. J Alzheimers Dis (2013) 0.84
Effects of hypertension and diabetes on sentence comprehension in aging. J Gerontol B Psychol Sci Soc Sci (2012) 0.83
Synergistic effects of the MTHFR C677T polymorphism and hypertension on spatial navigation. Biol Psychol (2008) 0.82
The impact of vascular comorbidities on qualitative error analysis of executive impairment in Alzheimer's disease. J Int Neuropsychol Soc (2009) 0.82
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes. Diabetologia (2015) 0.82
Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine. Int J Endocrinol (2015) 0.80
Insulin concentration is critical in culturing human neural stem cells and neurons. Cell Death Dis (2013) 0.80
Diabetes and the elderly brain: sweet memories? Ther Adv Endocrinol Metab (2012) 0.79
Cognitive decline in older Mexican Americans with diabetes. J Natl Med Assoc (2006) 0.79
Diabetes cognitive impairments and the effect of traditional chinese herbs. Evid Based Complement Alternat Med (2013) 0.78
Cognitive functioning is related to physical functioning in a longitudinal study of women at midlife. Gerontology (2009) 0.78
Hypertension and diabetes as risk factors for dementia: A secondary post-hoc analysis from north-west India. Ann Indian Acad Neurol (2015) 0.78
Effects of Astragalus polysaccharides on memory impairment in a diabetic rat model. Neuropsychiatr Dis Treat (2016) 0.78
Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States. Psychol Aging (2016) 0.77
Blood pressure and cognitive function: a prospective analysis among adolescents in Seychelles. J Hypertens (2013) 0.77
[Diabetes and dementia]. Z Gerontol Geriatr (2012) 0.77
Inhibition of synaptophysin ubiquitination may improve the intelligent drop due to high glucose and hypoxia. Int J Clin Exp Med (2014) 0.76
Diabetes and cognitive outcomes in a nationally representative sample: the National Health and Aging Trends Study. Int Psychogeriatr (2014) 0.76
ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial. Diabetologia (2016) 0.76
Advanced glycation end product-induced astrocytic differentiation of cultured neurospheres through inhibition of Notch-Hes1 pathway-mediated neurogenesis. Int J Mol Sci (2013) 0.76
Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study. Sleep (2016) 0.76
Cognitive decline and cardiometabolic risk among Hispanic and non-Hispanic white adults in the San Luis Valley Health and Aging Study. J Behav Med (2013) 0.76
Flos Puerariae Extract Ameliorates Cognitive Impairment in Streptozotocin-Induced Diabetic Mice. Evid Based Complement Alternat Med (2015) 0.76
Decreased response inhibition in middle-aged male patients with type 2 diabetes. Biopsychosoc Med (2010) 0.76
The Association between Patient-Reported Pain and Doctors' Language Proficiency in Clinical Practice. Pain Res Treat (2015) 0.75
Effect of cognitive status on exercise performance and quality of life in patients with symptomatic peripheral artery disease. J Vasc Surg (2015) 0.75
Cognition and health in African American men. J Aging Health (2014) 0.75
PTSD and cognitive symptoms relate to inhibition-related prefrontal activation and functional connectivity. Depress Anxiety (2017) 0.75
Fasting glucose and glucose tolerance as potential predictors of neurocognitive function among nondiabetic older adults. J Clin Exp Neuropsychol (2015) 0.75
Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity. Funct Neurol (2014) 0.75
Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC). PLoS One (2016) 0.75
Chronic, severe hypertension does not impair spatial learning and memory in Sprague-Dawley rats. Learn Mem (2001) 0.75
Different associations of premorbid intelligence vs. current cognition with BMI, insulin and diabetes in the homebound elderly. Integr Mol Med (2016) 0.75
Gut to Brain Dysbiosis: Mechanisms Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment. Front Behav Neurosci (2017) 0.75
The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study. Biomed Res Int (2016) 0.75
[Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study)]. Med Klin (Munich) (2008) 0.75
Celecoxib Alleviates Memory Deficits by Downregulation of COX-2 Expression and Upregulation of the BDNF-TrkB Signaling Pathway in a Diabetic Rat Model. J Mol Neurosci (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
A randomized trial of treatment options for alcohol-abusing workers. N Engl J Med (1991) 6.94
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
STATISTICAL METHODS AND CONTROL IN BACTERIOLOGY. Bacteriol Rev (1943) 6.32
The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med (1999) 6.22
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med (2001) 5.68
BIOLOGICAL DETERMINATION OF VITAMIN B1 (THIAMIN) IN RHIZOBIUM TRIFOLII. Science (1938) 5.59
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Mechanism of Biological Nitrogen Fixation: VI. Inhibition of Azotobacter by Hydrogen. Proc Natl Acad Sci U S A (1941) 5.23
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA (1993) 5.21
Formation of the nitrogen-fixing enzyme system in Azotobacter vinelandii. Can J Microbiol (1968) 5.05
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Mechanism of biological nitrogen fixation: Molecular H(2) and the pN(2) function of azotobacter. Biochem J (1941) 4.45
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med (1993) 4.30
A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med (1984) 4.29
Inverse association of dietary fat with development of ischemic stroke in men. JAMA (1998) 4.20
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med (1997) 3.96
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr (2001) 3.80
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Variability of body weight and health outcomes in the Framingham population. N Engl J Med (1991) 3.61
Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J (2000) 3.61
Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes (2000) 3.60
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
The Relationship Between Photosynthesis and Nitrogen Fixation. Proc Natl Acad Sci U S A (1952) 3.47
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
NITROGEN FIXATION BY PHOTOSYNTHETIC BACTERIA. J Bacteriol (1949) 3.33
Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology (2010) 3.27
INFLUENCE OF POTASSIUM NITRATE ON NODULE FORMATION AND NITROGEN FIXATION BY CLOVER. Plant Physiol (1932) 3.23
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord (2003) 3.23
Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation (2001) 3.18
Prevention of childhood injuries: evaluation of the Statewide Childhood Injury Prevention Program (SCIPP). Am J Public Health (1989) 3.17
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 3.09
Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr (1994) 3.08
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
ENZYME LOCALIZATION IN Azotobacter Vinelandii. Proc Natl Acad Sci U S A (1955) 2.97
Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology (2004) 2.97
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Improved cloning vectors and transformation procedure for Lactococcus lactis. J Appl Bacteriol (1993) 2.91
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91
The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg (1993) 2.91
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87
Cardiorespiratory events recorded on home monitors: Comparison of healthy infants with those at increased risk for SIDS. JAMA (2001) 2.87
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81